TP53 and hepatocellular carcinoma: In an analysis of the ctDNA from 121 patients with advanced HCC using targeted ultra-deep sequencing, the TERT promoter was present in 51%, TP53 in 32%, CTNNB1 in 17%, and PTEN in 8%, while other, less frequent mutations were also identified [110].